loader image
26 08, 2019

Modified drug combination may reduce risk of recurrence for some breast cancer patients

2020-12-11T15:59:44+01:00Agosto 26th, 2019|Pubblicazioni|0 Commenti

Masey Ross, M.D., and Charles Geyer, Jr., M.D. Credit: VCU Massey Cancer Center Oncologists at VCU Massey Cancer Center were invited to co-author [...]

20 08, 2019

Patient preferences explored in multiple myeloma treatment

2020-12-11T16:06:49+01:00Agosto 20th, 2019|Pubblicazioni|0 Commenti

(HealthDay)—An Eastern Cooperative Oncology Group (ECOG) performance status of ≥2 is linked to lower treatment satisfaction in patients with relapsed or refractory multiple myeloma (RRMM), [...]

19 08, 2019

Many clinical trials for new cancer drugs didn’t include any data on race

2020-12-11T16:08:23+01:00Agosto 19th, 2019|Pubblicazioni|0 Commenti

One-third of the clinical trials that led to new cancer drugs approved between 2008 and 2018 didn’t report on the race of trial participants — [...]

15 08, 2019

Study finds lack of racial diversity in cancer drug clinical trials

2020-12-02T16:12:39+01:00Agosto 15th, 2019|Pubblicazioni|0 Commenti

New research published this week in JAMA Oncology has found a lack of racial and ethnic diversity in clinical trials for cancer drugs. The study—conducted by researchers [...]

Torna in cima